Company Filing History:
4 out of 280 
4 out of 1,745 
4 out of 97 
Years Active: 2015-2019
Title: The Innovative Contributions of Isabelle Navarro-Teulon
Introduction
Isabelle Navarro-Teulon is a prominent inventor based in Saint Gely du Fesc, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody-based therapies. With a total of 4 patents to her name, her work has the potential to impact cancer treatment significantly.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Pharmaceutical compositions comprising an antibody which binds the human anti-Müllerian hormone receptor type II." This invention relates to novel pharmaceutical compositions that include an active ingredient, an antibody binding the human anti-Müllerian hormone type II receptor (AMHR-II), along with an anticancer agent. The therapeutic applications of these compositions are promising for cancer treatment. Another notable patent is for "Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II." This patent introduces novel mutated humanized 12G4 antibodies and their fragments, specifically directed against the anti-Müllerian hormone type II receptor.
Career Highlights
Isabelle has worked with esteemed institutions such as Université de Montpellier and Institut National de la Santé et de la Recherche Médicale. Her research and innovations have garnered attention in the scientific community, showcasing her dedication to advancing medical science.
Collaborations
Throughout her career, Isabelle has collaborated with notable professionals, including Christian Behrens and Christine Gaucher. These partnerships have contributed to her success and the development of her innovative patents.
Conclusion
Isabelle Navarro-Teulon exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations highlight her commitment to improving cancer therapies. Her work continues to inspire future advancements in medical research.